Inotiv Inc (NOTV)
4.33
-0.37
(-7.87%)
USD |
NASDAQ |
Apr 19, 16:00
4.33
0.00 (0.00%)
After-Hours: 20:00
Inotiv Debt to Equity Ratio: 1.492 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.492 |
September 30, 2023 | 1.404 |
June 30, 2023 | 1.360 |
March 31, 2023 | 1.366 |
December 31, 2022 | 1.329 |
September 30, 2022 | 0.9814 |
June 30, 2022 | 0.5519 |
March 31, 2022 | 0.5466 |
December 31, 2021 | 0.441 |
September 30, 2021 | 1.575 |
June 30, 2021 | 0.4993 |
March 31, 2021 | 3.709 |
December 31, 2020 | 3.633 |
September 30, 2020 | 3.611 |
June 30, 2020 | 2.990 |
March 31, 2020 | 2.441 |
December 31, 2019 | 2.128 |
September 30, 2019 | 1.550 |
June 30, 2019 | 1.388 |
March 31, 2019 | 1.030 |
December 31, 2018 | 0.8588 |
September 30, 2018 | 0.8687 |
June 30, 2018 | 0.4929 |
March 31, 2018 | 0.4963 |
December 31, 2017 | 0.5077 |
Date | Value |
---|---|
September 30, 2017 | 0.5175 |
June 30, 2017 | 0.5698 |
March 31, 2017 | 0.6061 |
December 31, 2016 | 0.5411 |
September 30, 2016 | 0.6723 |
June 30, 2016 | 0.5716 |
March 31, 2016 | 0.5239 |
December 31, 2015 | 0.50 |
September 30, 2015 | 0.423 |
June 30, 2015 | 0.4067 |
March 31, 2015 | 0.4853 |
December 31, 2014 | 0.5648 |
September 30, 2014 | 0.5705 |
June 30, 2014 | 0.5524 |
March 31, 2014 | 0.5144 |
December 31, 2013 | 0.6078 |
September 30, 2013 | 0.705 |
June 30, 2013 | 0.6226 |
March 31, 2013 | 0.6498 |
December 31, 2012 | 0.6751 |
September 30, 2012 | 0.8698 |
June 30, 2012 | 0.6187 |
March 31, 2012 | 0.5889 |
December 31, 2011 | 0.5392 |
September 30, 2011 | 0.5541 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.441
Minimum
Dec 2021
3.709
Maximum
Mar 2021
1.737
Average
1.404
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Avid Bioservices Inc | 0.7685 |
Macrogenics Inc | 0.00 |
Synlogic Inc | 0.00 |
BioXcel Therapeutics Inc | -1.780 |
IGM Biosciences Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 835.51M |
Total Liabilities (Quarterly) | 581.35M |
Shareholders Equity (Quarterly) | 254.16M |
Current Ratio | 1.742 |
Net Debt Paydown Yield | -5.43% |